Research progress on drugs in treatment of diabetic cardiomyopathy by regulating biomarkers
Diabetic cardiomyopathy is a serious complication caused by diabetes,and there is no effective targeted drug therapy strategy. The early biomarkers of diabetic cardiomyopathy have important clinical significance for the early diagnosis of diabetes cardiomyopathy and the reduction of mortality caused by it,and also have important guiding significance for the development and efficacy evaluation of related drugs. This article summarized the application of traditional clinical diagnostic markers,inflammation related markers,myocardial fibrosis related markers,and myocardial remodeling related markers in the drug treatment of diabetic cardiomyopathy,and summarized the drug research progress of regulating biomarkers in treatment of diabetic cardiomyopathy,hoping to provide reference for the efficacy evaluation of related drugs.
NETL
NSTL
万方数据
